Announced on February 10, Eli Lilly is expanding its collaboration with AdvanCell to advance targeted alpha therapies for cancer treatment. By using AdvanCell’s Pb-212 production technology and ...

SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the ...

The University of Queensland will play a key role in a national effort to revolutionize treatment for men with prostate cancer.